3 FTSE 100 stocks I’d buy in an ISA and hold forever

G A Chester discusses the special qualities of three FTSE 100 (INDEXFTSE:UKX) stocks he’d buy and hold for a very, very long time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I wouldn’t recommend owning a portfolio of just three stocks. But if someone put a gun to my head and told me I had to buy a trio of FTSE 100 companies in an ISA and hold them forever, which three would I pick, and why?

I’d be looking for a few key things. First, diversification across different industries (more specifically, industries that are likely to be around for decades to come). Second, geographical diversification. And third, a culture and history of prudent, long-term management.

With these things in mind, the blue-chip stocks I’d buy are Associated British Foods (LSE: ABF), Hikma Pharmaceuticals (LSE: HIK) and Schroders (LSE: SDR). Let me tell you more about these businesses and my thinking.

Industry diversification

ABF’s revenues are split approximately 50/50 between consumer goods (grocery, ingredients, sugar and animal feeds) and consumer services (clothing retail, namely Primark). Healthcare firm Hikma’s revenue comes entirely from pharmaceuticals, but is diversified across three segments (injectables, generics and branded). Schroders is in the financial industry, and the majority of its revenue comes from asset management, but some from private banking and associated wealth management services.

Will there ever come a time when the world no longer needs food or clothes? I can’t see it, and I reckon ABF owns attractive businesses in these areas.

Meanwhile, it’s widely believed ageing populations in the western world and rising wealth in emerging markets will fuel demand for healthcare in the coming decades. I think Hikma’s pharmaceuticals businesses should benefit from this long-term tailwind.

Finally, Schroders, as an asset manager, is essentially a geared play on stock markets, which we know tend to rise over the long run. As such, provided the company is well managed, the stock should outperform a market like the FTSE 100 over a long holding period.

If I had to use my ISA allowance to buy these three companies, I’d put £10,000 in ABF and £5,000 in each of the other two. This would give me an equal 25% exposure to 4 of the 10 broad industry categories. Namely, consumer goods, consumer services, healthcare and financials.

Geographical diversification

As well as being happy with the business diversification, I’d also be happy with the geographical diversification. ABF, Hikma and Schroders all generate international revenues, and I calculate the aggregate exposure as: Europe, Middle East & Africa (37%), UK (27%), Americas (23%) and Asia-Pacific (13%).

Prudent long-term management

Management change at companies is inevitable over time, but I think the cultures and histories of Hikma, ABF and Schroders put them at an advantage in terms of maintaining continuity. They were founded in 1978, 1935 and 1804, respectively, and at all three companies, descendants of the founding families maintain a significant presence both on the shareholder register and in the boardroom.

At such companies, a strong balance sheet and prudent stewardship of the business ensure future security to the family, so longer-term planning takes priority over short-term results. I think this philosophy is well-aligned with the interests of an investor who is looking to buy a stock and never sell it.

Finally, I’m not too worried about near-term earnings multiples and dividend yields. All three stocks are currently trading at discounts to previous highs, and that’s good enough for me for a holding period of forever.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Associated British Foods and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

8%+ yields! Should I buy these FTSE 100 income shares this month?

Christopher Ruane weighs some pros and cons of two FTSE 100 shares, both of which have a dividend yield over…

Read more »